Management of tunneled-cuffed catheters in hemodialysis patients with hypotension and recurrent central venous thrombosis: A single-center retrospective cohort study.
{"title":"Management of tunneled-cuffed catheters in hemodialysis patients with hypotension and recurrent central venous thrombosis: A single-center retrospective cohort study.","authors":"Jibo Sun, Hong Fan, Tianlei Cui","doi":"10.1177/00368504251323761","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate management strategies of tunneled-cuffed catheters (TCCs) in hemodialysis (HD) patients with hypotension and recurrent central venous thrombosis.</p><p><strong>Methods: </strong>We retrospectively reviewed HD patients with hypotension treated at the West China Hospital. The initial catheter tip was positioned routinely in the superior vena cava (SVC). In the event of SVC thrombosis, stenosis, or obstruction, the catheter was adjusted to right atrial (RA) or SVC and RA junction, and then inferior vena cava (IVC). If thrombi completely dissolved, catheter tips were returned to the former section. Meanwhile, patients with central venous thrombus were treated with antiplatelet therapy. We analyzed the efficacy of the management strategy in HD with hypotension and recurrent central venous thrombosis.</p><p><strong>Results: </strong>By adjusting catheter tips following the above procedure, vascular access has persevered in all the patients. Nineteen deaths (90.5%) were recorded during a median follow-up period of 6 years. No fatal pulmonary embolism nor catheter complication-related deaths were observed. The minimal survival period after the procedure was 6 years. The catheter primary patency rates at 3, 6, and 12 months were 90.5%, 66.7%, and 38.1%, respectively. The secondary patency rates were 100.0%, 80.9%, and 57.1% at 3, 6, and 12 months, respectively.</p><p><strong>Conclusion: </strong>The insertion of the TCCs tips initially in SVC, then adjusting in SVC and RA junction, RA and IVC successively in the event of thrombosis combined with antiplatelet therapy may be considered effective to prolong the HD vintage in patients with hypotension.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"108 1","pages":"368504251323761"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11863222/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Progress","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1177/00368504251323761","RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate management strategies of tunneled-cuffed catheters (TCCs) in hemodialysis (HD) patients with hypotension and recurrent central venous thrombosis.
Methods: We retrospectively reviewed HD patients with hypotension treated at the West China Hospital. The initial catheter tip was positioned routinely in the superior vena cava (SVC). In the event of SVC thrombosis, stenosis, or obstruction, the catheter was adjusted to right atrial (RA) or SVC and RA junction, and then inferior vena cava (IVC). If thrombi completely dissolved, catheter tips were returned to the former section. Meanwhile, patients with central venous thrombus were treated with antiplatelet therapy. We analyzed the efficacy of the management strategy in HD with hypotension and recurrent central venous thrombosis.
Results: By adjusting catheter tips following the above procedure, vascular access has persevered in all the patients. Nineteen deaths (90.5%) were recorded during a median follow-up period of 6 years. No fatal pulmonary embolism nor catheter complication-related deaths were observed. The minimal survival period after the procedure was 6 years. The catheter primary patency rates at 3, 6, and 12 months were 90.5%, 66.7%, and 38.1%, respectively. The secondary patency rates were 100.0%, 80.9%, and 57.1% at 3, 6, and 12 months, respectively.
Conclusion: The insertion of the TCCs tips initially in SVC, then adjusting in SVC and RA junction, RA and IVC successively in the event of thrombosis combined with antiplatelet therapy may be considered effective to prolong the HD vintage in patients with hypotension.
期刊介绍:
Science Progress has for over 100 years been a highly regarded review publication in science, technology and medicine. Its objective is to excite the readers'' interest in areas with which they may not be fully familiar but which could facilitate their interest, or even activity, in a cognate field.